Global Burden, Trends, and High‐ BMI ‐Attributable Risk of Hip Osteoarthritis: An Analysis of GBD 2021 Data
International Journal of Rheumatic Diseases · 2026
DOI: 10.1111/1756-185x.70727 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2026. Verfasst von Xueming Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthodontics, Tianjin Stomatological Hospital, School of Medicine, Nankai University, Tianjin, China. Hauptthemen laut MEDLINE: Osteoarthritis, Hip, Body Mass Index. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Tianjin Education Commission (Natural Science).
Abstract (Originalsprache)
Background
The purpose of this study is to evaluate the global burden of hip osteoarthritis (OA) and investigate its risk factors using Global Burden of Disease (GBD) 2021 data and Mendelian randomization (MR).
Methods
Hip OA burden was assessed by region, age, sex, and Socio‐Demographic Index (SDI). Temporal trends were evaluated using Joinpoint regression‐derived average annual percentage change (AAPC). Two‐sample MR and mediation analysis explored causal risk factors. Future burden from 2022 to 2050 was primarily projected using a Bayesian age‐period‐cohort (BAPC) model, with autoregressive integrated moving average (ARIMA) analysis used as a sensitivity comparison.
Results
The global age‐standardized hip OA prevalence was 416.01/100000 in 2021. The incidence and prevalence varied widely across countries. Males who were above 70 years old had a greater incidence of hip OA. The incidence and prevalence positively correlated with SDI, with the largest rise in incident cases occurring in middle SDI regions. Joinpoint analysis showed that the global burden of hip OA increased significantly from 1990 to 2021, with AAPCs of 0.2206 for incidence, 0.1879 for prevalence, and 0.1846 for DALYs. The most pronounced increases were observed in low‐middle and middle SDI regions. High body mass index (BMI) contributed to a 21.2% increase in disability‐adjusted life years (DALYs) from 1990 to 2021. MR mediation supported a positive association between higher BMI and hip OA and suggested that palmitoyl sphingomyelin may represent a potential mediator. The primary BAPC model suggested that the burden of hip OA would remain substantial through 2050, whereas comparison with ARIMA indicated model‐dependent uncertainty in the long‐term magnitude of the forecasts.
Conclusions
Our study provides valuable insights into the global epidemiological trends and risk factors of hip OA. These findings can help formulate policies and allocate resources, although long‐term projections should be interpreted cautiously because they are sensitive to model choice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthodontics, Tianjin Stomatological Hospital, School of Medicine, Nankai University, Tianjin, China.
- Tianjin Key Laboratory of Oral and Maxillofacial Function Reconstruction, Tianjin, China.
- School of Clinical Stomatology, Tianjin Medical University, Tianjin, China.
- School of Medicine, Nankai University, Tianjin, China.
Förderung
- Tianjin Education Commission (Natural Science)
Zitieren
APA
Shi, X., Lin, C., Yang, J., Cao, Z., & Duan, X. (2026). Global Burden, Trends, and High‐ BMI ‐Attributable Risk of Hip Osteoarthritis: An Analysis of GBD 2021 Data. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70727
Vancouver
Shi X, Lin C, Yang J, Cao Z, Duan X. Global Burden, Trends, and High‐ BMI ‐Attributable Risk of Hip Osteoarthritis: An Analysis of GBD 2021 Data. International Journal of Rheumatic Diseases. 2026. doi:10.1111/1756-185x.70727
BibTeX
@article{Shi2026,
author = {Shi, Xueming and Lin, Chen and Yang, Jiaying and Cao, Zhiwei and Duan, Xiaoning},
title = {Global Burden, Trends, and High‐ BMI ‐Attributable Risk of Hip Osteoarthritis: An Analysis of GBD 2021 Data},
journal = {International Journal of Rheumatic Diseases},
year = {2026},
doi = {10.1111/1756-185x.70727}
}
EUVIMED